{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T00:28:16Z","timestamp":1793665696917,"version":"4.5.1"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["neurology.org"],"crossmark-restriction":true},"short-container-title":["Neurology"],"published-print":{"date-parts":[[2010,2,2]]},"DOI":"10.1212\/wnl.0b013e3181ccc6ef","type":"journal-article","created":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T16:54:11Z","timestamp":1265043251000},"page":"413-420","update-policy":"https:\/\/doi.org\/10.1212\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":174,"title":["Pregabalin for painful HIV neuropathy"],"prefix":"10.1212","volume":"74","author":[{"given":"D. M.","family":"Simpson","sequence":"first","affiliation":[{"name":"From the Mount Sinai School of Medicine (D.M.S.), New York, NY; University of Rochester (G.S.), Rochester, NY; Washington University School of Medicine (D.B.C.), St. Louis, MO; Pfizer Global Pharmaceuticals (T.K.M., E.D.-D.C., E.W., B.E.), New York, NY; Otago University (P.G.), Dunedin, New Zealand; UBC Scientific Solutions (G.N.S.), Southport, CT; and Beth Israel Deaconess Medical Center (R.F.), Boston, MA. Drs. Durso\u2013De Cruz and Glue were employed by Pfizer Inc. at the time this study was conducted."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Schifitto","sequence":"additional","affiliation":[{"name":"From the Mount Sinai School of Medicine (D.M.S.), New York, NY; University of Rochester (G.S.), Rochester, NY; Washington University School of Medicine (D.B.C.), St. Louis, MO; Pfizer Global Pharmaceuticals (T.K.M., E.D.-D.C., E.W., B.E.), New York, NY; Otago University (P.G.), Dunedin, New Zealand; UBC Scientific Solutions (G.N.S.), Southport, CT; and Beth Israel Deaconess Medical Center (R.F.), Boston, MA. Drs. Durso\u2013De Cruz and Glue were employed by Pfizer Inc. at the time this study was conducted."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. B.","family":"Clifford","sequence":"additional","affiliation":[{"name":"From the Mount Sinai School of Medicine (D.M.S.), New York, NY; University of Rochester (G.S.), Rochester, NY; Washington University School of Medicine (D.B.C.), St. Louis, MO; Pfizer Global Pharmaceuticals (T.K.M., E.D.-D.C., E.W., B.E.), New York, NY; Otago University (P.G.), Dunedin, New Zealand; UBC Scientific Solutions (G.N.S.), Southport, CT; and Beth Israel Deaconess Medical Center (R.F.), Boston, MA. Drs. Durso\u2013De Cruz and Glue were employed by Pfizer Inc. at the time this study was conducted."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. K.","family":"Murphy","sequence":"additional","affiliation":[{"name":"From the Mount Sinai School of Medicine (D.M.S.), New York, NY; University of Rochester (G.S.), Rochester, NY; Washington University School of Medicine (D.B.C.), St. Louis, MO; Pfizer Global Pharmaceuticals (T.K.M., E.D.-D.C., E.W., B.E.), New York, NY; Otago University (P.G.), Dunedin, New Zealand; UBC Scientific Solutions (G.N.S.), Southport, CT; and Beth Israel Deaconess Medical Center (R.F.), Boston, MA. Drs. Durso\u2013De Cruz and Glue were employed by Pfizer Inc. at the time this study was conducted."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Durso-De Cruz","sequence":"additional","affiliation":[{"name":"From the Mount Sinai School of Medicine (D.M.S.), New York, NY; University of Rochester (G.S.), Rochester, NY; Washington University School of Medicine (D.B.C.), St. Louis, MO; Pfizer Global Pharmaceuticals (T.K.M., E.D.-D.C., E.W., B.E.), New York, NY; Otago University (P.G.), Dunedin, New Zealand; UBC Scientific Solutions (G.N.S.), Southport, CT; and Beth Israel Deaconess Medical Center (R.F.), Boston, MA. Drs. Durso\u2013De Cruz and Glue were employed by Pfizer Inc. at the time this study was conducted."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Glue","sequence":"additional","affiliation":[{"name":"From the Mount Sinai School of Medicine (D.M.S.), New York, NY; University of Rochester (G.S.), Rochester, NY; Washington University School of Medicine (D.B.C.), St. Louis, MO; Pfizer Global Pharmaceuticals (T.K.M., E.D.-D.C., E.W., B.E.), New York, NY; Otago University (P.G.), Dunedin, New Zealand; UBC Scientific Solutions (G.N.S.), Southport, CT; and Beth Israel Deaconess Medical Center (R.F.), Boston, MA. Drs. Durso\u2013De Cruz and Glue were employed by Pfizer Inc. at the time this study was conducted."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Whalen","sequence":"additional","affiliation":[{"name":"From the Mount Sinai School of Medicine (D.M.S.), New York, NY; University of Rochester (G.S.), Rochester, NY; Washington University School of Medicine (D.B.C.), St. Louis, MO; Pfizer Global Pharmaceuticals (T.K.M., E.D.-D.C., E.W., B.E.), New York, NY; Otago University (P.G.), Dunedin, New Zealand; UBC Scientific Solutions (G.N.S.), Southport, CT; and Beth Israel Deaconess Medical Center (R.F.), Boston, MA. Drs. Durso\u2013De Cruz and Glue were employed by Pfizer Inc. at the time this study was conducted."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Emir","sequence":"additional","affiliation":[{"name":"From the Mount Sinai School of Medicine (D.M.S.), New York, NY; University of Rochester (G.S.), Rochester, NY; Washington University School of Medicine (D.B.C.), St. Louis, MO; Pfizer Global Pharmaceuticals (T.K.M., E.D.-D.C., E.W., B.E.), New York, NY; Otago University (P.G.), Dunedin, New Zealand; UBC Scientific Solutions (G.N.S.), Southport, CT; and Beth Israel Deaconess Medical Center (R.F.), Boston, MA. Drs. Durso\u2013De Cruz and Glue were employed by Pfizer Inc. at the time this study was conducted."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. N.","family":"Scott","sequence":"additional","affiliation":[{"name":"From the Mount Sinai School of Medicine (D.M.S.), New York, NY; University of Rochester (G.S.), Rochester, NY; Washington University School of Medicine (D.B.C.), St. Louis, MO; Pfizer Global Pharmaceuticals (T.K.M., E.D.-D.C., E.W., B.E.), New York, NY; Otago University (P.G.), Dunedin, New Zealand; UBC Scientific Solutions (G.N.S.), Southport, CT; and Beth Israel Deaconess Medical Center (R.F.), Boston, MA. Drs. Durso\u2013De Cruz and Glue were employed by Pfizer Inc. at the time this study was conducted."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Freeman","sequence":"additional","affiliation":[{"name":"From the Mount Sinai School of Medicine (D.M.S.), New York, NY; University of Rochester (G.S.), Rochester, NY; Washington University School of Medicine (D.B.C.), St. Louis, MO; Pfizer Global Pharmaceuticals (T.K.M., E.D.-D.C., E.W., B.E.), New York, NY; Otago University (P.G.), Dunedin, New Zealand; UBC Scientific Solutions (G.N.S.), Southport, CT; and Beth Israel Deaconess Medical Center (R.F.), Boston, MA. Drs. Durso\u2013De Cruz and Glue were employed by Pfizer Inc. at the time this study was conducted."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.61.4.546"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000218303.48113.5d"},{"key":"e_1_3_3_4_2","first-page":"153","year":"1995","unstructured":"Simpson DM, Tagliati M. Nucleoside analogue-associated peripheral neuropathy in human immunodeficiency virus infection. J Acquir Immune Defic Syndr Hum Retrovirol 1995;9:153\u2013161.","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200211080-00002"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1529-8027.2001.006001008.x"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncl.2008.04.001"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(95)00217-0"},{"key":"e_1_3_3_9_2","doi-asserted-by":"crossref","unstructured":"Breitbart W Passik S McDonald MV et al. Patient-related barriers to pain management in ambulatory AIDS patients. Pain 1998;76:9\u201316.","DOI":"10.1016\/S0304-3959(98)00018-9"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0885-3924(00)00140-8"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11908-004-0014-5"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0028-3908(01)00172-1"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-004-0529-6"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2004.05.001"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000145767.36287.A1"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2004.12.007"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2005.02.032"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpain.2007.05.003"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000055433.55136.55"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2004.01.001"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1185\/030079906X80404"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000244422.45278.ff"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2007.06.033"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.20983"},{"key":"e_1_3_3_25_2","first-page":"502","volume":"35","year":"2008","unstructured":"Mease PJ, Russell IJ, Arnold LM, et al. A randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with fibromyalgia. J Rheumatol 2008;35:502\u2013514.","journal-title":"J Rheumatol"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2008.02.027"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2007.09.005"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jspi.2003.06.014"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1152\/jn.1991.66.1.190"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/122.12.2245"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000177925.92714.a9"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1300059"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.51.6.1682"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000063304.88470.D9"}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.0b013e3181ccc6ef","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T11:23:24Z","timestamp":1711538604000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.0b013e3181ccc6ef"}},"subtitle":["A randomized, double-blind, placebo-controlled trial"],"short-title":[],"issued":{"date-parts":[[2010,2,2]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,2,2]]}},"alternative-id":["10.1212\/WNL.0b013e3181ccc6ef"],"URL":"https:\/\/doi.org\/10.1212\/wnl.0b013e3181ccc6ef","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2,2]]}}}